Campaign groups and legal representatives argue that Oxevision presents safety risks, claiming care staff have substituted direct human observations with digital monitoring, leading to fatal consequences.

Overview Debates Related claims Topics Sources

In 2021, NHS England raised serious patient safety concerns regarding Oxevision's usage and capability claims with the Medicines and Healthcare products Regulatory Agency.

Lio Health head of patient safety Laura Cozens stated at the Lampard Inquiry that Oxevision technology assists staff in critical safety interventions and should not be deemed unsafe.

A report by the European Academies Science Advisory Council and the Federation of European Academies of Medicine recommended that high-risk artificial intelligence systems in healthcare remain under strict human supervision.

Pope Leo XIV published the encyclical Magnifica Humanitas in May 2026 calling for artificial intelligence to serve human dignity, social justice, and vulnerable populations.

Canada should exclude mental illness as a sole condition for medically assisted dying

A Department for Education spokesperson stated the UK government is developing screen-time guidance for children aged five to 18 and consulting on artificial intelligence and edtech safety.

Outro plans to use its $7 million in capital to expand its network of deprescribing clinicians and develop artificial intelligence clinical decision support tools.

Approximately one in six Americans take an antidepressant medication, and average duration of use has surpassed five years.

Outro's deprescribing platform incorporates personalized hyperbolic tapering plans, compounded medication doses, patient monitoring, and specially-trained clinicians.

Outro plans to expand its tapering model into additional medication classes beyond antidepressants, including benzodiazepines, gabapentinoids, and GLP-1s.

Research led by Dr. Mark Horowitz found that four in five long-term antidepressant users were unable to stop taking their medications due to withdrawal symptoms.

Hyperbolic tapering is the most effective protocol for discontinuing psychiatric medications

Commercial digital platforms are suitable for managing complex psychiatric drug withdrawal

U.S. healthcare providers should prioritize deprescribing over long-term psychiatric medication maintenance

FDA approval standards based on short-term trials adequately protect long-term antidepressant users

The risk of clinician deskilling outweighs the efficiency gains of diagnostic AI tools

Victoria should launch targeted public health campaigns on cannabis risks for young women

Cannabis-related admissions create an unsustainable strain on Victoria's public health system

Cannabis consumption poses a severe public health risk through induced psychosis

A NHS report into mental health services following Suzanne Brown's killing identified eight failures, including a lack of risk assessments or professional monitoring after Jake Neate's clozapine was stopped.